Effective solutions for FSIAD
Client
-
PROJECT DELIVERY
Freya Pharma Solutions
-
2022
The client
Freya Pharma Solutions is a late clinical stage company focused on developing effective pharmaceutical therapies for FSIAD, building upon fifteen years of solid research. The company has two compounds in development, Lybrido and Lybridos, to address the range of potential causes of FSIAD. Freya aims to offer patients a convenient, personalized ‘on demand’ solution for this recognized unmet medical need.
The challenge
Freya wanted support with a rebrand after acquiring all IP for their pharmaceutical products from another company.
Anner Eggink
Our expertise
We provided Freya with a new look and website from which to focus on relaunching their product development.
Looking for communication support?
